Primer: Enzychem Lifesciences Corp (183490 KS) - Aug 2026
Enzychem is a clinical-stage biotechnology company with a dual business model: a high-risk, high-reward drug development pipeline centered on...
107 Views
Alpha Generating Trading Strategy of KOSDAQ150 Deletions & Additions in June 2022
An alpha generating trading strategy would be to focus on companies with higher probability of getting deleted in the next round of KOSDAQ...
519 Views
EM Strategy:Â Russia and Thailand Bullishly Inflecting; Pullback Opportunity in India
This report highlights actionable themes across the EM universe, including: bullish inflections in the Russian and Thai markets, and a pullback...
648 Views
Enzychem Lifesciences Corp (183490 KS): Picked New Drug Development as Future Growth Engine
The company’s lead drug candidate, EC-18 is in late-stage clinical trial for an unmet need in oncology, chemoradiation-induced oral mucositis,...
607 Views
KOSDAQ150 Index Rebalance Preview: A Dozen Changes in June
There are 12 adds/deletes for the KOSDAQ150 in June. Most of the inclusions were expected while there appears to be discretion used in choosing the...
706 Views